SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-058655
Filing Date
2021-11-12
Accepted
2021-11-12 16:02:07
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_orionbiotech.htm   iXBRL 10-Q 441757
2 CERTIFICATION PURSUANT TO RULES 13A-14(A) AND 15D-14(A) f10q0921ex31-1_orionbio.htm EX-31.1 16635
3 CERTIFICATION PURSUANT TO RULES 13A-14(A) AND 15D-14(A) f10q0921ex31-2_orionbio.htm EX-31.2 16795
4 CERTIFICATION f10q0921ex32-1_orionbio.htm EX-32.1 6597
5 CERTIFICATION f10q0921ex32-2_orionbio.htm EX-32.2 6606
  Complete submission text file 0001213900-21-058655.txt   3176929

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE oria-20210930.xsd EX-101.SCH 48071
7 XBRL CALCULATION FILE oria-20210930_cal.xml EX-101.CAL 21163
8 XBRL DEFINITION FILE oria-20210930_def.xml EX-101.DEF 194618
9 XBRL LABEL FILE oria-20210930_lab.xml EX-101.LAB 352963
10 XBRL PRESENTATION FILE oria-20210930_pre.xml EX-101.PRE 200237
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_orionbiotech_htm.xml XML 292885
Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40410 | Film No.: 211403232
SIC: 6770 Blank Checks
Office of Real Estate & Construction